ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0944

A Characterization of the Gut and Cutaneous Microbiome of Monozygotic Twins Discordant for Psoriatic Disease

Julia Manasson1, Matthew Stapylton2, Rhina Medina1, Rochelle Castillo3, Parvathy Vasudevanpillai Girija1, Adriana Heguy1, Carles Ubeda4, Mid-Atlantic Twin Registry (MATR)5, Jose Clemente2 and Jose Scher1, 1New York University School of Medicine, New York, NY, 2Icahn Institute for Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai, New York, NY, 3NYU Langone Health, New York, NY, 4La Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana, Valencia, Spain; CIBERESP, Madrid, Spain, 5Virginia Commonwealth University, Richmond, VA

Meeting: ACR Convergence 2021

Keywords: microbiome, Monozygotic twins, psoriasis, Psoriatic arthritis, Psoriatic disease

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 7, 2021

Title: Abstracts: Spondyloarthritis Including PsA – Basic Science (0944–0947)

Session Type: Abstract Session

Session Time: 9:00AM-9:15AM

Background/Purpose: Psoriasis (PsO) is an inflammatory, immune-mediated skin disorder affecting ~3% of the population worldwide. It is associated with multiple comorbidities, including psoriatic arthritis (PsA), which occurs in up to a third of patients. While genes contribute to the pathogenesis of psoriatic disease, twin studies demonstrate substantial discordance in PsO and PsA, suggesting that epigenetics and environmental factors play a significant role. In fact, there is increasing evidence that the microbiome has an impact on psoriatic disease pathogenesis. However, prior investigations were performed in populations of unrelated individuals and could not discern environmental from genetic influences. To characterize the host-microbiome relationship, we studied the gut and skin microbiome of monozygotic (MZ) twins discordant for psoriatic disease in order to determine disease-specific microbial perturbations that are independent of host-genes.

Methods: Stool and skin swabs were collected from subjects with psoriatic disease and their unaffected MZ twin siblings (pairs=9, n=18). Non-lesional (NL) or healthy skin was swabbed at three separate sites: bicep, scalp, and elbow/forearm. Fecal samples underwent shotgun metagenomic sequencing to deeply characterize the gut microbiome taxonomy and functional pathways at high resolution. Sequences were processed with the HUMAnN and MetaPhlAn2 pipelines. Skin swab samples underwent 16S rRNA sequencing to characterize the cutaneous bacterial microbiome. Forward sequences were processed with the QIIME2 pipeline and SILVA reference database. Downstream computational analysis was performed using several libraries in R, including DESeq2.

Results: In gut samples, the relative abundance of Ruminococcus bromii species was significantly reduced and two pathways related to tetrahydrofolate biosynthesis were upregulated in psoriatic twins compared to their corresponding unaffected siblings (Fig 1; p< 0.05, Mann-Whitney). In NL skin samples from psoriatic twins, there was a significant reduction in alpha diversity and beta diversity differences in microbial communities of the scalp, but not the bicep or elbow/forearm, compared to healthy samples from unaffected twins (Fig 2A-B; p< 0.05, Mann-Whitney and Permanova). Differential analysis of taxa in the scalp identified a higher abundance of the Bacillales order and related taxa, as well as a lower abundance of the Deinococcus genus and related taxa in psoriatic twins compared to their unaffected siblings (Fig 2C; p< 0.05 with FDR correction).

Conclusion: This is the first study exploring microbial differences in MZ twins discordant for psoriatic disease. In agreement with our previous results, we found that Ruminococcus is reduced or virtually absent in the gut of psoriatic patients, and may therefore be associated with psoriatic disease. Additionally, we discovered that even healthy-appearing NL skin of psoriatic subjects, particularly in the scalp, exhibited microbial perturbations and decreased diversity compared to unaffected twins. A further understanding of these changes and their downstream effects should shed light into the pathogenesis of psoriatic disease beyond genetic susceptibility.

Figure 1. Monozygotic (MZ) twins discordant for psoriatic disease demonstrate differences in their gut microbial features. Psoriatic twins show a significant reduction in Ruminococcus bromii species (A), and a higher abundance of two tetrahydrofolate biosynthesis pathways (B) compared to their unaffected siblings (p<0.05, Mann-Whitney).

Figure 2. The cutaneous microbiome of non-lesional (NL) skin from the scalp of monozygotic (MZ) psoriatic twins is different from corresponding healthy skin of their unaffected siblings. (A) Alpha diversity is significantly reduced in the scalp of psoriatic twins compared to their unaffected siblings (p<0.05, Mann-Whitney; observed features and Faith’s phylodiversity), but not in the bicep or elbow/forearm. (B) There is a significant difference in the beta diversity of scalp microbial communities between psoriatic and unaffected twins (p<0.05, Permanova; unweighted UniFrac), but not in the bicep or elbow/forearm. (C) Differential abundance analysis with DESeq2 demonstrates a higher abundance of the Bacillales order and related taxa, and a lower abundance of the Deinococcus genus and related taxa in psoriatic twins compared to their unaffected siblings (p<0.05 with FDR correction). Prior to DESeq2 analysis, features were filtered to ensure that every feature was present in at least 2 samples in order to minimize outliers.


Disclosures: J. Manasson, None; M. Stapylton, None; R. Medina, None; R. Castillo, None; P. Vasudevanpillai Girija, None; A. Heguy, None; C. Ubeda, None; M. (MATR), None; J. Clemente, None; J. Scher, Janssen, 2, 5, Novartis, 2, 5, Pfizer, 2, 5, AbbVie, 2, Sanofi, 2, Kaleido, 2, UCB, 2.

To cite this abstract in AMA style:

Manasson J, Stapylton M, Medina R, Castillo R, Vasudevanpillai Girija P, Heguy A, Ubeda C, (MATR) M, Clemente J, Scher J. A Characterization of the Gut and Cutaneous Microbiome of Monozygotic Twins Discordant for Psoriatic Disease [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/a-characterization-of-the-gut-and-cutaneous-microbiome-of-monozygotic-twins-discordant-for-psoriatic-disease/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/a-characterization-of-the-gut-and-cutaneous-microbiome-of-monozygotic-twins-discordant-for-psoriatic-disease/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology